Jump to any asset
850 assets, updated daily
As of September 12, 2026, CME Group Inc. (CME) trades at $275.54. CleaRank Financial AI rates it Hold with a fair value of $285.00, 3.4% above the current price. Wall Street's consensus target is $285.00 across 16 analysts. RSI at 51 is in neutral territory, and the price is above its 50-day average of $262.67.
CME Group Inc. (CME)
CME Group Inc. NASDAQ
$275.54
1.470 (0.54%)
At close: Sep 11, 4:00 PM EDT
AI Analyst Consensus
59 / 100
CME Group Inc. (CME) is currently trading at $275.54, below its 200-day moving average of $278.80 but above its 50-day moving average of $262.67. The company operates in the Financial Services sector, specifically within Financial Data & Stock Exchanges, and holds a significant market capitalization of $99.1 billion. Recent earnings have shown a slight beat in the latest quarter, with EPS of $2.99 against an estimate of $2.91, contributing to a positive price reaction. However, insider activity indicates a net selling stance, with total sales of $37.6 million compared to purchases of $659.6 thousand, signaling a 'Moderate Sell Signal' from an insider perspective. Wall Street analysts maintain a mixed 'Hold' consensus, with a score of 59 out of 100, based on 16 analysts. The median price target is $285.00, suggesting a modest upside of 3.4% from the current price. Revenue growth has been modest at 0.8% year-over-year, with forward estimates projecting around 10.00% for the current quarter and 8.00% for the current year. The company also offers a dividend yield of approximately 4.10%.
CME Price Analysis
Market Metrics
Open
$275.35
Day Range
$271.30 to $276.15
Prev Close
$274.07
Volume
1.05M
52-Week Range
$218.31 to $329.16
Market Cap
$99.08B
Peer Benchmarking
Valuation vs Sector (Financial Services)
Performance vs KBE
Sector Position Analysis
Trading at a significant premium to sector peers (+41%), suggesting market expectations for superior growth or market position.
CME Analysis
Company's Health
4/5
12-Month Analyst Target
+3.43% Upside
Median of 16 analysts (12-month)
$285.00
AI Technical Analysis
CME Group Inc. is currently trading above its 50-day Simple Moving Average of $262.67, indicating near-term positive momentum, but remains below its 200-day Simple Moving Average of $278.80, suggesting a longer-term downtrend. The Relative Strength Index (RSI) is at 50.73, which is neutral, and the MACD indicator is positive at 3.78, suggesting a balanced momentum. The nearest support level is the 50-day SMA at $262.67, while resistance is observed near the 200-day SMA at $278.80. Trading volume has been significantly below average, down 46.9%, which may indicate a lack of strong conviction from market participants. The current price action suggests a consolidation phase, with key levels to watch being the 50-day SMA for support and the 200-day SMA for resistance.
ProTips
- Monitor upcoming earnings reports closely, as recent performance has shown mixed results with slight beats and misses.
- Pay attention to insider transaction activity; a continuation of the net selling trend could signal caution.
- Given the stock is trading below its 200-day SMA, consider risk management strategies such as setting stop-loss orders near the 50-day SMA support level.
Key Catalysts
Bullish
Positive Revenue Growth Estimates
Wall Street analysts project strong revenue growth for CME Group Inc., with an estimated +10.00% for the current quarter and +8.00% for the current year, which could drive positive price action.
Source: Wall Street EstimatesBearish
Moderate Insider Selling Signal
Insiders have sold a significant amount ($37.6 million) compared to purchases ($659.6 thousand), indicating a 'Moderate Sell Signal' that may weigh on investor sentiment.
Source: Insider TransactionsNeutral
Trading Below 200-Day Moving Average
CME Group Inc. is currently trading below its 200-day SMA of $278.80, suggesting a potential longer-term downtrend or consolidation phase that requires monitoring.
Source: Technical AnalysisBullish
Recent Earnings Beat
The latest earnings report showed an EPS beat of 2.75% ($2.99 actual vs $2.91 estimate), leading to a positive price reaction of 2.04%.
Source: Earnings ReportMarket Outlook
The base case outlook for CME Group Inc. anticipates a period of consolidation around its current price, with potential for a modest upward move towards the median analyst target of $285.00, representing a 3.4% upside. Forward revenue growth estimates are positive, projecting around 10.00% for the current quarter and 8.00% for the full year, which could support the stock price if realized. However, several factors could alter this trajectory. A failure to meet forward revenue expectations or increased insider selling could pressure the stock lower, potentially testing the 50-day SMA support at $262.67. Conversely, a strong earnings beat or positive macroeconomic developments favoring exchanges could push the price towards the 200-day SMA resistance at $278.80 and beyond. The current valuation premium relative to sector peers also presents a headwind for significant upside.
Key Statistics
| Market Cap | 98.99M |
|---|---|
| P/E Ratio | 23.27 |
| EPS (TTM) | 11.78 |
| Dividend Yield | 4.10% |
| 52 Week High | 329.16 |
| 52 Week Low | 218.31 |
CME Group Inc. exhibits a Price-to-Earnings (P/E) ratio of 23.27, which is notably higher than the sector median of 16.5, suggesting a premium valuation relative to its peers in the Financial Services industry. The company's earnings per share (EPS) for the trailing twelve months is $11.78. While revenue growth was a modest 0.8% year-over-year, forward estimates from Wall Street analysts project revenue growth of approximately 10.00% for the current quarter and 8.00% for the current year, indicating expected acceleration. The company's Return on Equity (ROE) is not directly provided but sector averages stand at 13.8%. The current price of $275.54 is trading below the median analyst price target of $285.00, offering a limited upside potential of 3.4%. The dividend yield is approximately 4.10%, providing a steady income stream for investors. The valuation appears stretched compared to sector averages, but forward revenue growth estimates offer some support.
Earnings & Growth Analysis
CME Group Inc. most recently reported an EPS of $2.99 for the quarter ending July 22, 2026, surpassing the analyst estimate of $2.91 by 2.75% and resulting in a 2.04% price increase. Prior to this, the company missed estimates slightly in the April 2026 quarter (-0.3% surprise) and beat expectations in the February 2026 quarter (1.09% surprise). Overall, recent earnings performance shows a pattern of slight beats and misses, with the latest quarter demonstrating positive momentum.
Key Risks
A primary risk for CME Group Inc. is its valuation, with a P/E ratio of 23.27 significantly higher than the sector median of 16.5, indicating potential downside if growth expectations are not met. Moderate insider selling, with $37.6 million in sales versus $659.6 thousand in purchases, suggests a lack of strong conviction from management. Also, the stock is trading below its 200-day moving average, signaling potential longer-term weakness.
Technical Indicators
| RSI (14) | 50.73 |
|---|---|
| MACD | 3.78 |
| SMA 50 | 262.67 |
| SMA 200 | 278.80 |
RSI
Neutral
SMA Cross
Bearish
Price vs SMA
Bullish
MACD
Bullish
Moving averages show a lagging Death Cross (50-day: $262.67, 200-day: $278.80), price sits above the 50-day SMA but below the 200-day SMA - a mixed posture.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
-0.10
Weak correlation
Nasdaq 100 (QQQ)
-0.19
Weak correlation
Bitcoin (BTC)
+0.08
Weak correlation
Gold (XAU)
+0.01
Weak correlation
Check Custom Correlation
Calculating correlation...
CME Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$272.78
Slight discount to current
Wait for small dip
AGGRESSIVE
$275.54
At current price
Enter now if confident
Risk Management
STOP LOSS
$264.60
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (50.7) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$280.97
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$286.42
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$294.61
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for CME is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 12, 2026.Growth of $10,000
A $10,000 investment in CME in September 2016 would be worth about $25,471 today, compared with about $35,328 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CME today could grow to about $22,643 by 2036 in the base case, with a bull case near $61,164 and a bear case around $8,382. Projections are statistical simulations, not guarantees.
CME Stock Price Prediction: 2030
CleaRank's simulation projects a price near $382 for CME by 2030 in the base case, from $276 today (1.4x over 4 years). The downside path ends near $204. These are outcomes of a Monte Carlo simulation run on CME's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $218 | $299 | $409 |
| 2028 | $208 | $324 | $506 |
| 2029 | $204 | $352 | $607 |
| 2030 | $204 | $382 | $716 |
| 2031 | $205 | $415 | $837 |
| 2032 | $208 | $450 | $971 |
| 2033 | $213 | $488 | $1,121 |
| 2034 | $218 | $530 | $1,289 |
| 2035 | $224 | $575 | $1,476 |
| 2036 | $231 | $624 | $1,685 |
Method: 10,000 simulated price paths using CME's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CME Insider Trading Analysis
Bought
$659.6K
4 Transactions
Sold
$37.6M
27 Transactions
Insiders
32
Active Traders
Avg Transaction
$1.2M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 35.0K | $10.4M |
| Apr 29, 2024 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 40.0K | $8.4M |
| Dec 12, 2019 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 39.3K | $8.0M |
| Mar 11, 2025 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 30.0K | $7.8M |
| Aug 1, 2019 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 35.0K | $7.0M |
| Dec 11, 2025 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 25.0K | $6.7M |
| Aug 18, 2023 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 30.0K | $6.1M |
| May 19, 2021 | DUFFY TERRENCE A
Chief Executive Officer
|
Sell | 29.0K | $6.1M |
| Jul 28, 2023 | CUTINHO SUNIL KIRAN
Chief Technology Officer
|
Sell | 19.4K | $3.9M |
| Feb 10, 2022 | KOMETER KEVIN D
Chief Technology Officer
|
Sell | 13.5K | $3.3M |
Page 1 of 1
Frequently Asked Questions
Is CME Group Inc. stock a buy right now?
CME Group Inc. is currently rated as 'Hold' by Wall Street analysts, with a consensus score of 59 out of 100. The median analyst price target is $285.00, suggesting a limited upside of 3.4% from the current price of $275.54. While recent earnings showed a slight beat, moderate insider selling and a P/E ratio above the sector average warrant caution.
What is CME Group Inc.'s price target for September 2026?
The median analyst price target for CME Group Inc. is $285.00, indicating a 3.4% upside from the current trading price of $275.54. This target is based on the consensus of 16 Wall Street analysts.
How is CME Group Inc.'s revenue growth trending?
CME Group Inc. reported a year-over-year revenue growth of 0.8%. However, forward estimates are more optimistic, with current quarter revenue growth projected at +10.00% and current year growth at +8.00%.
What are the key technical levels for CME Group Inc. stock?
CME Group Inc. is trading above its 50-day SMA of $262.67, which acts as support, but below its 200-day SMA of $278.80, which serves as resistance. The RSI is neutral at 50.73, and the MACD is positive, indicating a balanced momentum.
What is the insider sentiment for CME Group Inc. stock?
Insider sentiment for CME Group Inc. is currently leaning towards selling. Insiders have sold $37.6 million worth of stock compared to purchases of $659.6 thousand, resulting in a 'Moderate Sell Signal' and a net seller position.
How does CME Group Inc. compare to its sector averages?
CME Group Inc.'s P/E ratio of 23.27 is higher than the sector median of 16.5. Its revenue growth of 0.8% is below the sector median of 11.7%. However, its ROE is not provided, and its debt-to-equity ratio is estimated at 0.8, which is in line with typical sector figures.
What is CME Group Inc.'s dividend yield?
CME Group Inc. offers a dividend yield of approximately 4.10%, with a dividend rate of $11.30.
What is CME Group Inc.'s stock price prediction for 2030?
Based on Monte Carlo simulations, CME Group Inc.'s stock price is projected to be $382.08 in 2030 under a base case scenario, with a downside projection of $203.80 and an upside projection of $716.31. These are statistical outcomes, not guarantees.